资讯

News-Medical.Net on MSN15 小时
DT-109 shows promise in treating atherosclerosis and liver disease
A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis - a primary driver of cardiovascular death worldwide - in large mammals, a study suggests.
Drug candidate successfully treats atherosclerosis and fatty liver disease in large mammals
A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis—a primary driver of ...
Metabolic changes may drive estrogen receptor-negative breast cancer
They also found that lipids redirect metabolism to the serine, one-carbon, glycine (SOG) pathway, which is significantly associated with the development of ERneg breast cancer, and the methionine ...